Skip to main content

Advertisement

Table 2 Clinical and anthropometric variables and menopausal symptoms (n = 86)

From: Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial

  Baseline E2 E2+P P
BMI 26.3 ± 3 26.29 ± 3 26.23 ± 3.1 0.8
Weight (kg) 65.5 ± 8.3 65.58 ± 8.3 65.4 ± 8.6 0.7
Waist circumference (cm) 84.3 ± 7.5 84.2 ± 7.6 83.5 ± 7.4 0.06
Systolic blood pressure 118.6 ± 13.5 115 ± 14.9 116.7 ± 14.3 0.1
Diastolic blood pressure 76.2 ± 7.3 74.7 ± 9.5 74.9 ± 9.7 0.4
Kupperman score 26 (17–30)a 6 (0–12.5)b 4 (0–8)b < 0.01
E2 (pg/mL) 13 (5–19)a 54 (13–122)b 48 (13–80)b < 0.01
  1. Values expressed as median and interquartile range or mean ± SD. P = two-way analysis of variance with repeated measures (non parametric variables were log-converted for statistical analysis and reconverted for presentation in table format).
  2. Different superscript letters indicate statistical difference with Bonferroni multiple-comparison correction test (α < 5%).
  3. Baseline: before hormone therapy; E2: estradiol only; E2+P estradiol + micronized progesterone.
  4. BMI body mass index.